Accounting for glucose variation across the menstrual cycle is also imperative for individuals with conditions like type 1 diabetes, as increased glucose levels during the luteal phase may lead to hyperglycemia in diabetic individuals and should be considered when planning insulin therapy26. This evidence concerns the gene INS and type 1 diabetes mellitus.